상세 보기
Pegylated Liposomal Doxorubicin (PLD) and bevacizumab combination for recurrent ovarian cancer
Pegylated Liposomal Doxorubicin (PLD) and bevacizumab combination for recurrent ovarian cancer
- 제목
- Pegylated Liposomal Doxorubicin (PLD) and bevacizumab combination for recurrent ovarian cancer
- 제목 (타언어)
- Pegylated Liposomal Doxorubicin (PLD) and bevacizumab combination for recurrent ovarian cancer
- 저자
- Min Kyung-Jin
- 발행일
- 2022-12-10
- 학회명
- ASGO 2022 Review course
- 개최국가
- 대한민국
- 학회 개최일
- 2022-12-10 ~ 2022-12-10